RxDoctor Payments Data

Adam Bisaga

Addiction Psychiatry · Ardsley, NYNPI 1023135613

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $7,975 of the $9,269 with a category attached, or 86.0%. Eli Lilly accounts for 89.7% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $8,580, more than ten times the $97 reported in 2022. Among addiction psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,269in general payments, 2019–2025

Across 13 payments — averaging $713.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$8K
  • Braeburn Inc.$543
  • Alkermes, Inc.$120
  • Indivior Inc.$106
  • Corium, LLC$97
  • AbbVie$88
$1,027,841in research payments, 2019–2025

Across 13 payments — averaging $79,065 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alkermes, Inc.$1M

What the payments were for

  • Consulting fees$7,97586%
  • Travel & lodging$2953%
  • Food & beverage$1,00011%

General payments by program year

22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Eli Lilly4$8,315
Braeburn Inc.5$543
Alkermes, Inc.1$120
Indivior Inc.1$106
Corium, LLC1$97
AbbVie1$88

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,269 in reported general payments places this provider in the 95th percentile of 43 addiction psychiatry providers in New York.

See all addiction psychiatry providers in New York →

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$3,224

Paid to pharmacies, not to this prescriber.

Other addiction psychiatry in Ardsley

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →